Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
10-year CHD risk evaluation and its treatment pattern analysis in postmenopausal early breast cancer patients taking aromatase inhibitors.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The primary objective of this study is to define 10-year CHD risk according to Framingham risk score in postmenopausal early breast cancer patients who are taking aromatase inhibitors as an adjuvant treatment. | 1 visit |
| Measure | Description | Time Frame |
|---|---|---|
| To describe 10-year CHD risk comparing to the historical data of 10-year cancer-specific mortality in breast cancer | 1 Visit | |
| To analyse CHD management patterns according to defined 10-year CHD risk categories | 1 Visit |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Postmenopausal patients with early breast cancer, who are taking aromatase inhibitors no longer than 6 months as an adjuvant treatment after surgery
Not provided
| Name | Affiliation | Role |
|---|---|---|
| JoonWoo Bahn, MD, PhD | AstraZeneca Korea | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Cheonan | Chungcheongnam-do | South Korea | |||
| Research Site |
Not provided
Not provided
Not provided
Not provided
| To describe correlation between concommitant medication(Anthracycline, Trasuzumab) and CHD risk | 1 Visit |
| Chuncheon |
| Gangwon-do |
| South Korea |
| Research Site | Goyang-si | Gyeonggi-do | South Korea |
| Research Site | Seongnam-si | Gyeonggi-do | South Korea |
| Research Site | Pohang | Gyeongsangbuk-do | South Korea |
| Research Site | Masan-si | Gyeongsangnam-do | South Korea |
| Research Site | Anyang | South Korea |
| Research Site | Busan | South Korea |
| Research Site | Daegu | South Korea |
| Research Site | Daejeon | South Korea |
| Research Site | Gangneung | South Korea |
| Research Site | GuangJu | South Korea |
| Research Site | Gwangju | South Korea |
| Research Site | Incheon | South Korea |
| Research Site | Inchon | South Korea |
| Research Site | Jeonju | South Korea |
| Research Site | Junam | South Korea |
| Research Site | Koyang | South Korea |
| Research Site | Kyunggi | South Korea |
| Research Site | Pusan | South Korea |
| Research Site | Seoul | South Korea |
| Research Site | Seoul(Kangbuk) | South Korea |
| Research Site | Seoul(Kangdong) | South Korea |
| Research Site | Seoul(Kangnam) | South Korea |
| Research Site | Seoul(Yeouido) | South Korea |
| Research Site | Suwon | South Korea |
| Research Site | Ulsan | South Korea |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided